BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37203347)

  • 21. Characteristics of the Voice Handicap Index for Patients With Unilateral Vocal Fold Paralysis Who Underwent Arytenoid Adduction.
    Watanabe K; Sato T; Honkura Y; Kawamoto-Hirano A; Kashima K; Katori Y
    J Voice; 2020 Jul; 34(4):649.e1-649.e6. PubMed ID: 30616964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term voice outcomes of medialization thyroplasty with adjustable implant for unilateral vocal fold paralysis.
    Huang PK; Chen CK; Yu YH; Ho GM; Hsieh LC
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1371-1378. PubMed ID: 38085304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voice outcome in medialisation thyroplasty with and without arytenoid adduction: a prospective comparison using intraoperative voice measurements.
    Mes SD; van der Jagt MA; Jansen JC; Langeveld APM; Sjögren EV; Heijnen BJ
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2499-2505. PubMed ID: 38365991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of pitch range after arytenoid adduction by fenestration approach combined with type I thyroplasty for unilateral vocal fold paralysis.
    Tokashiki R; Hiramatsu H; Shinada E; Motohashi R; Nomoto M; Toyomura F; Suzuki M
    J Voice; 2012 Nov; 26(6):792-6. PubMed ID: 22417985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unilateral Vocal Fold Paralysis With Large Posterior Glottic Gap: Is Arytenoid Procedure Necessary?
    Yılmaz T; Özer F
    Ann Otol Rhinol Laryngol; 2022 Aug; 131(8):859-867. PubMed ID: 34535066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term postoperative vocal function after thyroplasty type I and fat injection laryngoplasty.
    Umeno H; Chitose S; Sato K; Ueda Y; Nakashima T
    Ann Otol Rhinol Laryngol; 2012 Mar; 121(3):185-91. PubMed ID: 22530479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic unilateral vocal fold paralysis following cardiothoracic surgery.
    Puccinelli C; Modzeski MC; Orbelo D; Ekbom DC
    Am J Otolaryngol; 2018; 39(2):175-179. PubMed ID: 29254704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective analysis of revision framework surgeries for unilateral vocal fold paralysis.
    Kishimoto Y; Hiwatashi N; Kawai Y; Fujimura S; Sogami T; Hayashi Y; Omori K
    Braz J Otorhinolaryngol; 2022; 88(5):767-772. PubMed ID: 33419650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonselective Laryngeal Reinnervation versus Type 1 Thyroplasty in Patients with Unilateral Vocal Fold Paralysis: A Single Tertiary Centre Experience.
    Ab Rani A; Azman M; Ubaidah MA; Mohamad Yunus MR; Sani A; Mat Baki M
    J Voice; 2021 May; 35(3):487-492. PubMed ID: 31732294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glottic closure patterns: type I thyroplasty versus type I thyroplasty with arytenoid adduction.
    Li AJ; Johns MM; Jackson-Menaldi C; Dailey S; Heman-Ackah Y; Merati A; Rubin AD
    J Voice; 2011 May; 25(3):259-64. PubMed ID: 20335002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A "fenestration approach" for arytenoid adduction through the thyroid ala combined with type I thyroplasty.
    Tokashiki R; Hiramatsu H; Tsukahara K; Kanebayashi H; Nakamura M; Motohashi R; Yamada T; Suzuki M
    Laryngoscope; 2007 Oct; 117(10):1882-7. PubMed ID: 17690612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arytenoid vertical height discrepancy in predicting outcomes after unilateral vocal cord medialization.
    Wong E; Smith M; Stone DB; Palme CE; Smith MC; Riffat F
    Laryngoscope; 2020 Feb; 130(2):418-422. PubMed ID: 30843620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medialization Thyroplasty and Arytenoid Adduction for Management of Neurological Vocal Fold Immobility.
    Prasad VMN; Remacle M
    Adv Otorhinolaryngol; 2020; 85():85-97. PubMed ID: 33166967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary Clinical Outcomes of VOIS-Implant in Patients With Unilateral Vocal Fold Paralysis.
    Hsieh LC; Chen CK; Chang CW; Leu YS; Ho GM
    Laryngoscope; 2022 Aug; 132(8):1622-1629. PubMed ID: 34817072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of trans-nasal fiberendoscopic injection laryngoplasty with centrifuged autologous fat in the treatment of glottic insufficiency due to unilateral vocal fold paralysis.
    Ricci Maccarini A; Stacchini M; Mozzanica F; Schindler A; Basile E; DE Rossi G; Woo P; Remacle M; Magnani M
    Acta Otorhinolaryngol Ital; 2018 Jun; 38(3):204-213. PubMed ID: 29984796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arytenoid asymmetry: Is it the most predictive parameter for arytenoid adduction in unilateral vocal fold paralysis?
    Menon JR; Mathew AS; Nath S
    J Laryngol Otol; 2021 Feb; 135(2):159-167. PubMed ID: 33593469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Effects of Fat Injection Laryngoplasty in Relation to the Injected Fat Volume in Patients With Unilateral Vocal Fold Paralysis.
    Umeno H; Tanaka HI; Kurita T; Mihashi R; Chitose SI; Sato K
    J Voice; 2022 Sep; ():. PubMed ID: 36127213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of voice and quantitative measurement of glottal gap after thyroplasty type I in the treatment of unilateral vocal paralysis.
    Shin JE; Nam SY; Yoo SJ; Kim SY
    J Voice; 2002 Mar; 16(1):136-42. PubMed ID: 12002881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Impact of the Montgomery Implant System on Arytenoid Cartilage and the Paralyzed Vocal Fold.
    Storck C; Lüthi M; Honegger F; Unteregger F
    J Voice; 2020 Jan; 34(1):145-149. PubMed ID: 30172670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of type I thyroplasty and arytenoid adduction.
    Abraham MT; Gonen M; Kraus DH
    Laryngoscope; 2001 Aug; 111(8):1322-9. PubMed ID: 11568563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.